Skip to main content
. 2011 Jun;8(2):88–92. doi: 10.3724/SP.J.1263.2011.00088

Table 4. Target doses achieved of ACE inhibitors/ARBs and β-blockers.

Agents Target doses achieved n (%)
ACE inhibitors / ARBs 159 (40.3)
β-blockers 68 (28.9)